Found: 9
Select item for more details and to access through your institution.
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.
- Published in:
- Infection, 2022, v. 50, n. 5, p. 1321, doi. 10.1007/s15010-022-01833-8
- By:
- Publication type:
- Article
Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 53, doi. 10.3390/antibiotics10010053
- By:
- Publication type:
- Article
Experience with the use of siltuximab in patients with SARS-CoV-2 infection.
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 4, p. 337, doi. 10.37201/req/045.2021
- By:
- Publication type:
- Article
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 3, p. 238, doi. 10.37201/req/037.2021
- By:
- Publication type:
- Article
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 3, p. 1243, doi. 10.1007/s40121-022-00623-x
- By:
- Publication type:
- Article
Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1407, doi. 10.1007/s40121-021-00477-9
- By:
- Publication type:
- Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
- By:
- Publication type:
- Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
- By:
- Publication type:
- Article
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article